Piramal Pharma Limited has submitted an intimation to BSE Limited and National Stock Exchange of India Limited regarding its schedule of upcoming Analyst and Institutional Investor meetings. This disclosure is made pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The scheduled meetings are as follows:
- 2nd September 2026: Meeting with Ashwamedh-Elara India Dialogue 2026 in Mumbai
- 17th September 2026: Participation in Jefferies 5th India Forum in Gurgaon (Group/One-on-one Meeting format)
- 18th September 2026: Participation in Kotak Healthcare Forum in Mumbai (Investor Conference, Physical mode)
- 23rd-24th September 2026: Participation in Goldman Sachs Global Healthcare CDMO Day in Singapore
The company has noted that these dates are subject to changes due to exigencies on the part of either investors or the company.
The communication was digitally signed by Maneesh Sharma, Company Secretary & Compliance Officer of Piramal Pharma Limited, on 10th August, 2026 at 14:08:20 IST.